A reasonable explanation is that, on average, BRCA2-related cancers (like BRCA1-related cancers) have a faster doubling time than sporadic cancers [13], which increases their likelihood of presenting as palpable interval cancers rather than being detected on the next round of screening. Here, BRCA2 is linked to cancer.